Professional
Added to YB: 2024-09-10
Pitch date: 2024-06-30
DXCM [bullish]
DexCom, Inc.
-36.04%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$113.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
Carillon Eagle Mid Cap Growth Fund Porfolio Holding - DexCom, Inc.
DXCM: Pioneer in CGM systems for diabetics. Large untapped market vs finger prick tests. Stock down despite beating estimates & raising guidance. New products & insulin pump integration offer growth. Huge opportunity in Type 1 & growing Type 2 diabetic markets.
Read full article (1 min)